INNOVENT BIOLOGICS INC earnings per share and revenue

1801 earnings per share for the last semiannual are 0.19 HKD whereas the estimation was -0.24 HKD which accounts for 178.26% surprise. Company revenue for the same period amounts to 5.82 B HKD despite the estimated figure of 4.95 B HKD. Estimated earnings per share for the next semiannual are 0.24 HKD, and revenue is expected to reach 6.50 B HKD. Also watch annual changes over time to get a bigger picture of 1801 earnings per share and revenue dynamics.